Naltrexone Hydrochloride Accord Healthcare (Naltrexone Hydrochloride)

The drug acts as a competitive antagonist at mu, kappa and delta opioid receptors. By occupying these receptors without activating them, it prevents both endogenous opioids and external opioid drugs from producing their usual effects, thereby diminishing reinforcement and craving.

The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s medical condition, treatment goals, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Naltrexone Hydrochloride in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Healthcare providers should weigh potential benefits against risks and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naltrexone Hydrochloride shares the same opioid‑blocking mechanism as other antagonists such as naloxone, but it is formulated for oral administration and is primarily used for long‑term relapse prevention, whereas naloxone is typically administered parenterally for acute overdose reversal.

The product should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight to maintain potency and stability throughout its shelf life.

Naltrexone Hydrochloride is taken orally, usually as a tablet, with or without food as directed by the prescriber. Patients should swallow the tablet whole and avoid crushing or chewing unless instructed otherwise.

Serious risks include hepatotoxicity, severe depression or suicidal thoughts, and rare allergic reactions such as anaphylaxis. Patients should be monitored regularly for liver function and mental health changes, and any signs of severe adverse reactions require immediate medical attention.

Individuals currently undergoing opioid withdrawal, those with acute liver disease, or patients with known hypersensitivity to naltrexone should avoid using the medication. Additionally, it is contraindicated in patients who cannot safely discontinue opioid analgesics under medical supervision.